Long-Term Efficacy and Safety of Recombinant Human Hyaluronidase (rHuPH20)- Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (HyQvia; IGHy) in Patients with Primary Immunodeficiencies (PI)

Richard L. Wasserman, Mark R. Stein, Isaac Melamed, Lisa J. Kobrynski, Sudhir Gupta, Jennifer M. Puck, Arye Rubinstein, Werner Engl, Barbara McCoy, Heinz Leibl, Leman Yel
  • Journal of Allergy and Clinical Immunology, February 2015, Elsevier
  • DOI: 10.1016/j.jaci.2014.12.1247
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Richard L Wasserman